Isotroin

Isotretinoin, the active ingredient in Isotroin, is a retinoid presented as an oral dosage form for prescription use. It is indicated for the treatment of severe acne conditions in patients who have not responded to other therapies. GNH USA supplies Isotroin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isotretinoin is a retinoid that acts on the pilosebaceous unit to treat severe acne disorders. - Severe nodular acne: reduces inflammatory lesions and prevents new nodule formation. - Acne vulgaris: improves skin clearance and reduces comedones. - Refractory acne unresponsive to conventional therapy: provides an effective alternative when other treatments have failed.

Isotretinoin may cause a range of adverse reactions.

Common Side Effects: - Dry skin and mucous membranes, including cheilitis. - Photosensitivity and increased sunburn risk. - Elevated liver enzymes and triglyceride levels. - Musculoskeletal discomfort or arthralgia. - Nasal dryness and epistaxis. - Transient headache.

Serious or Rare Side Effects: - Severe depression or mood changes. - Inflammatory bowel disease flares. - Teratogenic effects leading to birth defects. - Pseudotumor cerebri (intracranial hypertension). - Severe hepatitis or liver failure. - Pancreatitis.

Before initiating isotretinoin therapy, clinicians should consider several safety measures. - Pregnancy: contraindicated due to high teratogenic risk; ensure effective contraception. - Women of child‑bearing potential: require regular pregnancy testing. - Baseline and periodic monitoring of liver function tests and lipid profile. - Avoid excessive sun exposure; use sunscreen and protective clothing. - Do not combine with tetracycline antibiotics because of increased intracranial hypertension risk. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Isotretinoin can interact with several medications, requiring careful management.

Major Interactions (Avoid): - Tetracyclines: increased risk of intracranial hypertension. - Vitamin A supplements: additive retinoid toxicity.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce isotretinoin efficacy. - Systemic corticosteroids: can mask signs of infection. - Lipid‑lowering agents (e.g., fibrates): may affect triglyceride levels.